NEW YORK (GenomeWeb News) – Bruker Daltonics has inked an exclusive distribution agreement for its MALDI Biotyper with Francisco Soria Melguizo in Spain.
The firm announced the pact this weekend at the 19th European Congress of Clinical Microbiology and Infectious Diseases.
The MALDI Biotyper uses high-throughput MALDI-TOF mass spectrometry for identification, taxonomical classification, and dereplication of microorganisms like bacteria, yeasts, and fungi. Francisco Soria Melguizo will distribute the Biotyper to labs conducting clinical microbiology and veterinary medicine in Spain.
Bruker launched the system in Germany last year and recently obtained an IVD-CE Mark for the system.
It also announced at the meeting that it has undertaken US collaborations for clinical validation of microbial identification using the Biotyper. Bruker did not disclose the identities of those collaborators, except for the Microbiology Service of the NIH Clinical Center in Bethesda, Md.